EUVIMEDSkopri EUVIMED
Crossref

Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1 ‐Dependent IRE1α ‐ XBP1 Pathway

Hui Zhuge iD, Kaixin Chang, Shuzhen Sun, Qinchao Ding, Shanglei Lai, Xiaobing Dou, Qing Song, Songtao Li

Phytotherapy Research · 2026

DOI: 10.1002/ptr.70406 ↗

At a glance

Journal article in Phytotherapy Research, 2026. Written by Hui Zhuge and 7 co-authors. Institution: School of Public Health, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China. Major MEDLINE topics: Sirtuin 1, Hepatocytes, Non-alcoholic Fatty Liver Disease, Lactones. 52 references. Funded by: National Natural Science Foundation of China.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Atractylenolide I (AO‐I), a major pharmacological ingredient derived from Atractylodes macrocephala , has been reported to possess multiple bioactivities. This study aimed to investigate the potential protective effects of AO‐I against lipotoxicity in both cultured hepatocytes and mice with non‐alcoholic fatty liver disease (NAFLD). The NAFLD model was established by feeding C57BL/6 mice a high‐fat diet (HFD) for 12 weeks. Oral administration of AO‐I at doses of 20 or 50 mg/kg body weight per day was explored. Lipotoxicity in AML12 hepatocytes was induced by incubation with palmitate for in vitro investigations on the roles of AO‐I. The results demonstrated that supplementation with AO‐I improved alanine transaminase (ALT), aspartate transaminase (AST), and liver histology in NAFLD mice. Furthermore, AO‐I directly alleviated palmitate‐induced lipotoxicity by reducing hepatocyte death. Mechanistic studies revealed that AO‐I significantly attenuated lipotoxicity through its potential resistance to endoplasmic reticulum (ER) stress and IRE1α‐XBP1 splicing both in vivo and in vitro. We identified that AO‐I substantially rescued HFD‐ and palmitate‐induced SIRT1 decline in mouse livers and hepatocytes, respectively, thereby improving liver injury and hepatocyte cell death. Mechanistic studies demonstrated that the amelioration of ER stress and lipotoxicity by AO‐I supplementation depended on SIRT1 activity. Moreover, AO‐I also mitigated IRE1α activation‐triggered JNK/p38 MAPK hyperphosphorylation. In conclusion, our findings suggest that AO‐I exhibits significant therapeutic effects for improving lipotoxicity in the liver and may be considered as a candidate for NAFLD therapy.

Subjects

MeSH terms (MEDLINE)

Sirtuin 1HepatocytesNon-alcoholic Fatty Liver DiseaseLactonesX-Box Binding Protein 1SesquiterpenesProtein Serine-Threonine KinasesEndoribonucleasesAnimalsMice, Inbred C57BLMiceMaleDiet, High-FatEndoplasmic Reticulum StressSignal TransductionLiverCell LineDisease Models, AnimalAlanine Transaminase

Author keywords

Atractylenolide IIRE1αSIRT1lipotoxicitypalmitate

Substances

Sirtuin 1LactonesX-Box Binding Protein 1SesquiterpenesErn1 protein, mouseProtein Serine-Threonine KinasesXbp1 protein, mouseSirt1 protein, mouseatractylenolide IEndoribonucleases

Authors and institutions

  • School of Public Health, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
  • School of Life Science, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China.
  • Department of Medical Research Center, Shaoxing People's Hospital, Zhejiang, China.
  • Department of Clinical Nutrition, Affiliated Zhejiang Hospital, School of Medicine, Zhejiang University, Zhejiang, Hangzhou, China.

ORCID profiles: Hui Zhuge

Funding

  • National Natural Science Foundation of China

Cite

APA

Zhuge, H., Chang, K., Sun, S., Ding, Q., Lai, S., Dou, X., Song, Q., & Li, S. (2026). Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1 ‐Dependent IRE1α ‐ XBP1 Pathway. Phytotherapy Research. https://doi.org/10.1002/ptr.70406

Vancouver

Zhuge H, Chang K, Sun S, Ding Q, Lai S, Dou X, et al. Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1 ‐Dependent IRE1α ‐ XBP1 Pathway. Phytotherapy Research. 2026. doi:10.1002/ptr.70406

BibTeX
@article{Zhuge2026,
  author = {Zhuge, Hui and Chang, Kaixin and Sun, Shuzhen and Ding, Qinchao and Lai, Shanglei and Dou, Xiaobing and Song, Qing and Li, Songtao},
  title = {Atractylenolide I Alleviates Lipotoxicity in Hepatocytes and Protects NAFLD in Mice Through SIRT1 ‐Dependent IRE1α ‐ XBP1 Pathway},
  journal = {Phytotherapy Research},
  year = {2026},
  doi = {10.1002/ptr.70406}
}
Start for free →